All Medications

Browse by specialty to learn about insurance denials, step therapy, and appeal strategies.

Oncology

Alecensa

ALK+ NSCLC

→
Aranesp

Anemia — CKD, chemotherapy-induced

→
Avastin

CRC, NSCLC, RCC, GBM, Cervical, Ovarian, HCC

→
Bosulif

CML (Ph+)

→
Cabometyx

RCC, HCC, Differentiated Thyroid Cancer

→
Calquence

CLL/SLL, Mantle Cell Lymphoma

→
Darzalex

Multiple Myeloma

→
Darzalex Faspro

Multiple Myeloma

→
Enhertu

HER2+ and HER2-low Breast Cancer, HER2+ Gastric, HER2-mutant NSCLC

→
Epogen

Anemia — CKD, chemotherapy, surgery, HIV/zidovudine

→
Erleada

nmCRPC, mCSPC

→
Herceptin

HER2+ Breast Cancer, HER2+ Gastric Cancer

→
Ibrance

HR+/HER2- Metastatic Breast Cancer

→
Imbruvica

CLL/SLL, Mantle Cell Lymphoma, Waldenström's

→
Jakafi

Myelofibrosis, Polycythemia Vera, Acute GVHD

→
Jemperli

dMMR Endometrial Cancer, dMMR Solid Tumors

→
Kanjinti

Biosimilar to Herceptin

→
Keytruda

NSCLC, Melanoma, Head/Neck, Bladder, MSI-H solid tumors, +15 indications

→
Kisqali

HR+/HER2- Metastatic Breast Cancer

→
Lenvima

Differentiated Thyroid Cancer, RCC, HCC, Endometrial Cancer

→
Lynparza

BRCA+ Ovarian, Breast, Prostate, Pancreatic Cancer

→
Mvasi

Biosimilar to Avastin

→
Neulasta

Chemotherapy-induced neutropenia prevention

→
Neupogen

Chemotherapy-induced neutropenia, PBPC mobilization

→
Nubeqa

nmCRPC, mHSPC

→
Ogivri

Biosimilar to Herceptin

→
Opdivo

NSCLC, Melanoma, RCC, Hodgkin Lymphoma, Head/Neck, Bladder, HCC, CRC, Esophageal

→
Perjeta

HER2+ Breast Cancer (combo with Herceptin)

→
Pluvicto

PSMA-positive mCRPC

→
Pomalyst

Multiple Myeloma

→
Procrit

Anemia — CKD, chemotherapy, surgery

→
Promacta

Chronic ITP, Aplastic Anemia, Hepatitis C Thrombocytopenia

→
Retacrit

Biosimilar to Epogen/Procrit

→
Retevmo

RET+ NSCLC, RET+ Thyroid Cancer, RET+ Solid Tumors

→
Revlimid

Multiple Myeloma, MDS del(5q), Mantle Cell Lymphoma

→
Rituxan

NHL, CLL, RA, GPA, MPA

→
Ruxience

Biosimilar to Rituxan

→
Sprycel

CML (Ph+), ALL (Ph+)

→
Tagrisso

EGFR-mutant NSCLC

→
Tasigna

CML (Ph+)

→
Truxima

Biosimilar to Rituxan

→
Venclexta

CLL/SLL, AML

→
Verzenio

HR+/HER2- Metastatic Breast Cancer

→
Xtandi

mCRPC, mCSPC, nmCRPC

→
Zarxio

Biosimilar to Neupogen

→
Zirabev

Biosimilar to Avastin

→
Zytiga

mCRPC, mCSPC

→